Key result
In terminally ill cancer patients, heart rate variability measured by SDNN was a significant independent prognostic factor for survival duration (HR 0.062, p=0.022).
Why the study?
Does heart rate variability predict survival duration in terminally ill hospice cancer patients?
Population
68 terminally ill cancer patients who visited a hospice clinic
Comparison
Heart rate variability measurement, specifically… vs Patients with higher SDNN and lower mean heart…
Design
Cohort
Authors
Loading...
SDNN may refine survival estimates in terminal cancer hospice care; leaves open whether it improves decision-making or requires prospective validation.
Cohort (n=68)
No
Does heart rate variability predict survival duration in terminally ill hospice cancer patients?
Hazard Ratio: 0.062 (95% CI 0.006–0.673)
p-value: p=0.022
Heart rate variability, specifically SDNN, serves as a significant independent prognostic factor for survival duration in terminal cancer patients.
Kim et al. (2010) conducted a cohort in Terminal cancer (n=68). Heart rate variability (SDNN) vs. Higher SDNN was evaluated on Survival duration (HR 0.062, 95% CI 0.006-0.673, p=0.022). In terminally ill cancer patients, heart rate variability measured by SDNN was a significant independent prognostic factor for survival duration (HR 0.062, p=0.022).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: